CDTX NASDAQ
Cidara Therapeutics, Inc.
1W: +0.0%
1M: +0.5%
3M: +129.3%
1Y: +832.4%
3Y: +1525.4%
5Y: +423.4%
$221.38
Last traded 2025-12-31 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
-100.0% YoY
$-185M
Net Income
-50.0% YoY
$-133M
Free Cash Flow
+17.0% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-68.7%
ROA-54.3%
ROIC-118.1%
Valuation
P/E-46.6
P/B8.1
EV/EBITDA-6.3
Leverage
Debt/Equity0.00
Current Ratio4.62
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z6.87
Beneish M0.00